Reprogenix
Hangzhou
About Reprogenix
Reprogenix is a groundbreaking medical technology firm that began with stem cell therapy for diabetes and is dedicated to expanding the use of cell therapy in a wide range of disease areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $84.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
- Website: reprogenix.comindex.html
- Phone: +86 0571-88610677
Industries & Categories
Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/reprogenix-74299 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.